Literature DB >> 9814555

Proteasome inhibitors which induce neurite outgrowth from PC12h cells cause different subcellular accumulations of multi-ubiquitin chains.

R Ohtani-Kaneko1, K Takada, M Iigo, M Hara, H Yokosawa, S Kawashima, K Ohkawa, K Hirata.   

Abstract

The effects of two proteasome inhibitors on neurite outgrowth from PC12h cells were investigated in terms of the mean length of the neurites and the frequency of occurrence of cells with long neurites. Benzyloxycarbonyl-leucyl-leucyl-leucinal (ZLLLal) and benzyloxycarbonyl-isoleucyl-t-butyl-glutamyl-leucinal (PSI) caused a significant elongation of PC12h cell neurites. Since ZLLLal is known to inhibit both calpain and proteasome activity, we examined the effects ofbenzyloxycarbonyl-leucyl-leucinal (ZLLal) which inhibits calpain activity to the same degree as ZLLLal, but which inhibits proteasome activity only weakly. ZLLal did not induce the significant elongation of neurites at any of the concentrations we studied. These results show that the inhibition of proteasome activity causes neurite elongation. We also quantified subcellular levels of multi-ubiquitin chains and free ubiquitin after treatments with PSI, ZLLLal and ZLLal. Treatment with ZLLal had no effects on levels of water- and urea-soluble multi-ubiquitin chains or of free ubiquitin either in the nucleus or in the cytoplasm. PSI and ZLLLal induced a large accumulation of water- and urea-soluble multi-ubiquitin chains and free ubiquitin in the nucleus. Similarly, PSI and ZLLLal increased cytoplasmic levels of urea-soluble multi-ubiquitin chains. On the contrary, PSI and ZLLLal had no effect on levels of water-soluble multi-ubiquitin chains or free ubiquitin in the cytoplasm. This is the first study to demonstrate subcellular differences in the accumulation of multi-ubiquitin chains and free ubiquitin during the neurite elongation induced by proteasome inhibitors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814555     DOI: 10.1023/a:1020763009488

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  49 in total

1.  Subcellular distribution of ubiquitin-protein conjugates in the hippocampus following transient ischemia.

Authors:  T Hayashi; K Takada; M Matsuda
Journal:  J Neurosci Res       Date:  1992-03       Impact factor: 4.164

Review 2.  Antigen processing and presentation by the class I major histocompatibility complex.

Authors:  I A York; K L Rock
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

3.  Apoptosis induction resulting from proteasome inhibition.

Authors:  K Shinohara; M Tomioka; H Nakano; S Toné; H Ito; S Kawashima
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

4.  Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases.

Authors:  A M Musti; M Treier; D Bohmann
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

5.  ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin.

Authors:  E Eytan; D Ganoth; T Armon; A Hershko
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Ability of ubiquitin radioimmunoassay to discriminate between monoubiquitin and multi-ubiquitin chains.

Authors:  K Takada; N Hibi; Y Tsukada; T Shibasaki; K Ohkawa
Journal:  Biochim Biophys Acta       Date:  1996-08-13

7.  The neurite-initiating effect of a tripeptide aldehyde protease inhibitor on PC12h cells.

Authors:  Y Saito; S Kawashima
Journal:  J Biochem       Date:  1989-12       Impact factor: 3.387

8.  Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins.

Authors:  W Seufert; B Futcher; S Jentsch
Journal:  Nature       Date:  1995-01-05       Impact factor: 49.962

9.  Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine.

Authors:  S Tsubuki; Y Saito; M Tomioka; H Ito; S Kawashima
Journal:  J Biochem       Date:  1996-03       Impact factor: 3.387

10.  Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids.

Authors:  M Orlowski; C Cardozo; C Michaud
Journal:  Biochemistry       Date:  1993-02-16       Impact factor: 3.162

View more
  5 in total

1.  Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.

Authors:  L Stefanis; K E Larsen; H J Rideout; D Sulzer; L A Greene
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  Rapid Ca2+-dependent decrease of protein ubiquitination at synapses.

Authors:  Hong Chen; Simona Polo; Pier Paolo Di Fiore; Pietro V De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

Review 3.  Isolevuglandin adducts in disease.

Authors:  Robert G Salomon; Wenzhao Bi
Journal:  Antioxid Redox Signal       Date:  2015-02-18       Impact factor: 8.401

4.  Retroviruses have differing requirements for proteasome function in the budding process.

Authors:  David E Ott; Lori V Coren; Raymond C Sowder; Julian Adams; Ulrich Schubert
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 5.  Axonal Organelles as Molecular Platforms for Axon Growth and Regeneration after Injury.

Authors:  Veselina Petrova; Bart Nieuwenhuis; James W Fawcett; Richard Eva
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.